In the United States and some countries other than Europe, Lilly owns exclusive development and commercialization rights to ...

Axcelead DDP generates drug candidates through its well-established drug discovery capabilities and innovative technologies, including AI. Leveraging its researchers' deep knowledge and extensive ...

Eli Lilly said the Food and Drug Administration approved its treatment for moderate-to-severe eczema that isn't well controlled despite treatment with topical prescription therapies.

The FDA has approved an Eli Lilly drug that offers a ... Regulators in Japan approved Ebglyss early this year. Lilly expects regulatory decisions for the drug in other markets later this year.

New data from the QWINT clinical trial may get Eli Lilly closer to bringing a once-weekly insulin injection to the US, ...

Eli Lilly said the Food and Drug Administration ... The treatment was approved for use by the European Commission in 2023, as well as in Japan in January. The company expects approval in ...

This roundup covers various health news highlights including the mpox outbreak in Africa and vaccine distribution issues, the ...

Eli Lilly and Co. ($LLY) announced that the U.S. Food and Drug Administration (FDA) had approved its atopic dermatitis ...

Eli Lilly said on Friday the U.S. Food and Drug Administration approved its eczema drug for use in adults and children above ...

Three years after establishing an immunology unit, Eli Lilly has gained its third FDA approval in the specialty area as the U ...

On Friday, the U.S. Food and Drug Administration approved Eli Lilly's eczema drug for use in adults and ... The drug is ...